Search

everythinglearnresearchcommunity

for

Search:↓

Single-cell encapsulation shows promise for medical use but faces production challenges.

Early diagnosis and a strict gluten-free diet are crucial for children with celiac disease to improve symptoms.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Use PRP and ASC-BT for hair loss and wound healing, but more research needed.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Exosomes could be a promising way to help repair skin and treat skin disorders.

Platelet-derived products help regenerate tissue and are used in various skin and hair treatments.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Microneedling improves skin and hair conditions by enhancing treatment absorption and stimulating growth factors.

Long-term high-dose fluconazole can cause reversible hair loss.

Nanoparticles improve skin treatment but need more research on safety and effectiveness.

Liposomes improve finasteride delivery for hair loss treatment, making it a promising option for topical use.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

Kampo medicine can help treat general fatigue from long COVID.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Most COVID-19 survivors developed post-acute symptoms, especially if they had been in the ICU, but the severity of initial infection didn't predict these symptoms.

Many people in Thailand have lingering symptoms after recovering from COVID-19.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

The conference highlighted new treatments and research in pediatric skin conditions, emphasizing collaboration and innovation.

Antibody treatments show promise for hair loss but need more research.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

Hair loss is common in Jazan, affecting more women, and skin diseases significantly impact mental health.